Joint Preservation Therapy Solutions in Peoria, AZ

CDC PLACES vs. JF: two files, not one brochure

Joe Bradley will tell you the same thing he tells his own staff: epidemiology first, then MAC, then SKU. CDC PLACES (2023, crude) estimates 10.5% of adults in Peoria have diagnosed diabetes — 1.5 points below the U.S. 12% figure. 10.3% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Then we pick joint preservation therapy against that mix.

Cash PRP and Medicare CTPs in the same hallway

• Adult arthritis here is 25.8% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. 10.3% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. PRP is autologous and not a 361 allograft, but “patient prefers regenerative” is still not medical necessity in Arizona.
• Nationwide shipping is the honest fulfillment model. There is no Hawk Medical warehouse promised inside Peoria city limits; account management and SOP support are what make a remote distributor usable.
• Medicare wound-care biologics in Arizona are paid under Noridian Healthcare Solutions (JF). CTP and skin-substitute LCDs are MAC-specific — a protocol that billed cleanly in another jurisdiction can stall here if documentation does not match JF coverage articles.

Payer geography for Peoria, AZ

JF reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Peoria is 10.5% or not. PLACES is planning data. The LCD is the claim.

How we’d stand this up in clinic